3 -amino-imidazo [1,2 -a] pyridine derivatives having an SGLT1 and SGLT2 inhibiting action, for treating type 1 and type 2 diabetes

Details for Australian Patent Application No. 2007312659 (hide)

Owner Merck Patent GmbH

Inventors Gericke, Rolf; Cezanne, Bertram; Klein, Markus; Mederski, Werner; Tsaklakidis, Christos; Beier, Norbert

Agent Davies Collison Cave

Pub. Number AU-B-2007312659

PCT Pub. Number WO2008/046497

Priority 10 2006 048 728.1 16.10.06 DE

Filing date 27 September 2007

Wipo publication date 24 April 2008

Acceptance publication date 30 August 2012

International Classifications

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/4745

A61P 3/10 Drugs for disorders of the metabolism

Event Publications

11 June 2009 PCT application entered the National Phase

  PCT publication WO2008/046497 Priority application(s): WO2008/046497

30 August 2012 Application Accepted

  Published as AU-B-2007312659

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007312665-Method and device for producing molten material

2007312628-Chip stack cutter devices for displacing chips in a chip stack and chip-stacking apparatuses including such cutter devices, and related methods